In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a Zymaxid Drug Master File in Korea (Zymaxid KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Zymaxid. The MFDS reviews the Zymaxid KDMF as part of the drug registration process and uses the information provided in the Zymaxid KDMF to evaluate the safety and efficacy of the drug.
After submitting a Zymaxid KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Zymaxid API can apply through the Korea Drug Master File (KDMF).
click here to find a list of Zymaxid suppliers with KDMF on PharmaCompass.